GSK, Sanofi COVID-19 vaccine won't be ready till late 2021 - Los Angeles Times
)
Sanofi, GSK say Covid booster shot works better against Omicron variant
Sanofi and GSK to seek regulatory authorization for Covid-19 vaccine
Britain Nears 500 Million Pound Deal For Sanofi, GSK COVID-19 Vaccine: Report
Covid Vaccine: CureVac, Novavax (NVAX), Glaxo (GSK), Sanofi (SNY) Race for Shots - Bloomberg
Sanofi and GSK to Seek Regulatory Authorization After “Robust Efficacy” Proven by COVID-19 Vaccine
Global PPE (@Global_PPE_Inc) / X
GSK, Sanofi say COVID-19 vaccine won't be ready until late 2021 - CBS News
GSK/Sanofi Covid booster delayed by lack of uninfected people to test it on, GlaxoSmithKline
Sanofi, GSK to seek COVID-19 vaccine candidate approval
Sanofi, GSK to seek approval for Covid vaccine candidate that prevents 100% of hospitalizations
A closer look at the vaccines Canada is betting on to stem the spread of COVID-19
